<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

PROSTATE CANCER

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 1999 English Publisher:Elsevier BVJournal:Medical Clinics of North America, volume 83, pages 1,231-1,245 (issn: 0025-7125,

Authors: L E, Hahnfeld; T D, Moon;

doi: 10.1016/s0025-7125(05)70160-7

pmid: 10503062

PROSTATE CANCER

- Summary
- Subjects
- Metrics

Abstract

Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.

Keywords

Diagnosis, Differential, Male, Prostatectomy, Antineoplastic Agents, Hormonal, Humans, Mass Screening, Prostatic Neoplasms, Prostate-Specific Antigen, Aged, Neoplasm Staging

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	8
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%